Source: T3 Advisors Blog

T3 Advisors Blog Design Considerations for cGMP Facilities

A Biotech and Pharmaceutical company's success is often attributed to its ability to design a scalable and productive process that can eventually be manufactured as quickly and cheaply as possible. Most of these companies have to approach the topic of how to manufacture their drug or technology to be commercially available to the public which [...]The post Design Considerations for cGMP Facilities appeared first on T3 Advisors.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Roy Hirshland's photo - Co-Founder & CEO of T3 Advisors

Co-Founder & CEO

Roy Hirshland

CEO Approval Rating

88/100

Read more